SOD1 and myocardial ischemia: Although several antioxidants, including recombinant human SOD, have undergone preliminary clinical trials for their potential therapeutic roles in eliminating ROS and managing MIRI, these treatments have demonstrated limited efficacy in improving heart function recovery in patients undergoing coronary angioplasty for myocardial ischemia.